Basis: FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the P/S ratio high or low?
The P/S ratio of 11.59 is 82% below its estimated 5-year average of 65.94, near the low end of its estimated 5-year range (11.59–2129.36).
As of 2026-10-06T11:10:52.426Z. 28.91% below its estimated 12-month average of 16.30.
Calculation as of: 2026-10-06T11:10:52.426Z.
Quote observation: 2026-10-05T20:00:02.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 3b719543d2ad964e34cebd38a4954272106044749b474b483c00e469aab85807
Current P/S: FMP quote market capitalization / TTM revenue. Historical estimates use price and reported weighted-average shares; daily points use adjusted close × quarterly weighted-average shares / TTM revenue. Historical series through 2026-10-05.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PS RATIO
11.59
PS RATIO AVG TTM
16.30
PS RATIO AVG 3Y
22.06
PS RATIO AVG 5Y
65.94
PS RATIO AVG 10Y
375.57
PS RATIO AVG 15Y
N/A
PS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-28.91%
CURRENT VS 3Y AVG
-47.45%
CURRENT VS 5Y AVG
-82.42%
CURRENT VS 10Y AVG
-96.91%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.91
median of 248 covered companies
CURRENT VS SECTOR MEDIAN
+196.42%
vs the sector median at left
Market Cap
$14.97B
PS Ratio
3.74
TTM Avg
2.49
3Y Avg
2.42
5Y Avg
2.85
Market Cap
$13.19B
PS Ratio
15.88
TTM Avg
10.72
3Y Avg
9.53
5Y Avg
8.58
| NAME | MARKET CAP | PS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Ascendis Pharma A/S (ASND) | $14.16B | 11.59 | 16.30 | 22.06 | 65.94 |
| Tempus AI, Inc. (TEM)vs › | $14.64B | 10.22 | 9.01 | 11.23 | 11.23 |
| Exelixis, Inc. (EXEL)vs › | $14.79B | 6.07 | 5.53 | 4.78 | 4.51 |
| Charles River Laboratories International, Inc. (CRL)vs › | $14.97B | 3.74 | 2.49 | 2.42 | 2.85 |
| Corcept Therapeutics Incorporated (CORT)vs › | $13.19B | 15.88 | 10.72 | 9.53 | 8.58 |
| Solventum Corporation (SOLV)vs › | $15.24B | 1.83 | 1.63 | 1.52 | 1.52 |
| BridgeBio Pharma, Inc. (BBIO)vs › | $12.95B | 18.17 | 30.73 | 140.86 | 124.76 |
| ICON Public Limited Company (ICLR)vs › | $12.89B | 1.56 | 1.46 | 2.10 | 2.47 |
| Baxter International Inc. (BAX)vs › | $12.52B | 1.09 | 0.95 | 1.26 | 1.65 |
| Penumbra, Inc. (PEN)vs › | $12.49B | 8.30 | 8.87 | 8.39 | 9.41 |
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
Reported statement amounts were converted from EUR to USD using the stored FMP exchange-rate calculation.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $250,669,590 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-12 |
| Q4 FY2025Period ended 2025-12-31 | $287,984,892 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-11 |
| Q1 FY2026Period ended 2026-03-31 | $289,588,203 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-07 |
| Q2 FY2026Period ended 2026-06-30 | $393,940,811 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-13 |
| TTM revenue | $1,222,183,496 |
Current P/S: $14,163,307,008 market capitalization ÷ $1,222,183,496 TTM revenue = 11.59x.
Market capitalization source: FMP quote. Quote observed 2026-10-05T20:00:02.000Z. Latest revenue period ended 2026-06-30.
At 11.59, P/S is at an extreme level, where the multiple carries little signal — higher than 0% of readings in its estimated 12-year history.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
estimated 12-year low
12.47
median
177.94
estimated 12-year high
6816.49
P/S Ratio
11.59
Market Cap / Trailing Twelve-Month Revenue
PS Ratio = Market Cap / Revenue (TTM)
The price-to-sales ratio compares market capitalization to trailing revenue. It is useful for valuing companies with little or no earnings.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | PS RATIO |
|---|---|
| 2026-10-05 | 12.75 |
| 2026-10-02 | 12.74 |
| 2026-10-01 | 12.71 |
| 2026-09-30 | 12.74 |
| 2026-09-29 | 12.75 |
| 2026-09-28 | 12.86 |
| 2026-09-25 | 12.61 |
| 2026-09-24 | 12.90 |
| 2026-09-23 | 12.47 |
| 2026-09-22 | 13.28 |
| 2026-09-21 | 13.28 |
| 2026-09-18 | 13.23 |
| 2026-09-17 | 13.36 |
| 2026-09-16 | 13.85 |
| 2026-09-15 | 13.40 |
| 2026-09-14 | 14.81 |
| 2026-09-11 | 14.73 |
| 2026-09-10 | 14.60 |
| 2026-09-09 | 14.58 |
| 2026-09-08 | 15.10 |
| 2026-09-04 | 15.12 |
| 2026-09-03 | 15.16 |
| 2026-09-02 | 14.94 |
| 2026-09-01 | 14.55 |
| 2026-08-31 | 14.70 |
| 2026-08-28 | 13.86 |
| 2026-08-27 | 13.94 |
| 2026-08-26 | 13.99 |
| 2026-08-25 | 14.14 |
| 2026-08-24 | 14.08 |
| 2026-08-21 | 14.16 |
| 2026-08-20 | 14.24 |
| 2026-08-19 | 14.51 |
| 2026-08-18 | 13.91 |
| 2026-08-17 | 13.83 |
| 2026-08-14 | 13.89 |
| 2026-08-13 | 15.66 |
| 2026-08-12 | 16.25 |
| 2026-08-11 | 16.19 |
| 2026-08-10 | 16.26 |
| 2026-08-07 | 16.24 |
| 2026-08-06 | 15.89 |
| 2026-08-05 | 15.53 |
| 2026-08-04 | 15.56 |
| 2026-08-03 | 15.48 |
| 2026-07-31 | 15.51 |
| 2026-07-30 | 15.97 |
| 2026-07-29 | 16.03 |
| 2026-07-28 | 16.18 |
| 2026-07-27 | 16.12 |
| 2026-07-24 | 16.15 |
| 2026-07-23 | 16.07 |
| 2026-07-22 | 16.02 |
| 2026-07-21 | 16.23 |
| 2026-07-20 | 16.01 |
| 2026-07-17 | 16.60 |
| 2026-07-16 | 16.52 |
| 2026-07-15 | 17.08 |
| 2026-07-14 | 16.89 |
| 2026-07-13 | 16.87 |
| 2026-07-10 | 17.20 |
| 2026-07-09 | 17.52 |
| 2026-07-08 | 17.63 |
| 2026-07-07 | 16.98 |
| 2026-07-06 | 17.04 |
| 2026-07-02 | 17.46 |
| 2026-07-01 | 17.03 |
| 2026-06-30 | 16.96 |
| 2026-06-29 | 16.77 |
| 2026-06-26 | 16.58 |
| 2026-06-25 | 16.64 |
| 2026-06-24 | 15.14 |
| 2026-06-23 | 15.17 |
| 2026-06-22 | 14.50 |
| 2026-06-18 | 14.68 |
| 2026-06-17 | 14.70 |
| 2026-06-16 | 14.70 |
| 2026-06-15 | 14.20 |
| 2026-06-12 | 13.87 |
| 2026-06-11 | 13.71 |
| 2026-06-10 | 13.34 |
| 2026-06-09 | 13.56 |
| 2026-06-08 | 13.09 |
| 2026-06-05 | 13.38 |
| 2026-06-04 | 13.92 |
| 2026-06-03 | 13.79 |
| 2026-06-02 | 13.78 |
| 2026-06-01 | 13.92 |
| 2026-05-29 | 14.25 |
| 2026-05-28 | 15.10 |
| 2026-05-27 | 14.96 |
| 2026-05-26 | 15.24 |
| 2026-05-22 | 15.71 |
| 2026-05-21 | 15.74 |
| 2026-05-20 | 15.35 |
| 2026-05-19 | 15.14 |
| 2026-05-18 | 15.11 |
| 2026-05-15 | 15.30 |
| 2026-05-14 | 15.61 |
| 2026-05-13 | 15.49 |
| 2026-05-12 | 15.11 |
| 2026-05-11 | 15.18 |
| 2026-05-08 | 15.18 |
| 2026-05-07 | 18.11 |
| 2026-05-06 | 17.36 |
| 2026-05-05 | 16.58 |
| 2026-05-04 | 16.83 |
| 2026-05-01 | 16.26 |
| 2026-04-30 | 16.88 |
| 2026-04-29 | 16.21 |
| 2026-04-28 | 16.34 |
| 2026-04-27 | 16.68 |
| 2026-04-24 | 16.87 |
| 2026-04-23 | 16.56 |
| 2026-04-22 | 17.00 |
| 2026-04-21 | 17.68 |
| 2026-04-20 | 18.06 |
| 2026-04-17 | 17.99 |
| 2026-04-16 | 17.88 |
| 2026-04-15 | 17.79 |
| 2026-04-14 | 18.39 |
| 2026-04-13 | 18.29 |
| 2026-04-10 | 17.61 |
| 2026-04-09 | 17.79 |
| 2026-04-08 | 17.16 |
| 2026-04-07 | 16.22 |
| 2026-04-06 | 16.68 |
| 2026-04-02 | 16.87 |
| 2026-04-01 | 16.80 |
| 2026-03-31 | 16.83 |
| 2026-03-30 | 16.07 |
| 2026-03-27 | 15.96 |
| 2026-03-26 | 16.23 |
| 2026-03-25 | 16.26 |
| 2026-03-24 | 15.86 |
| 2026-03-23 | 16.05 |
| 2026-03-20 | 16.33 |
| 2026-03-19 | 16.47 |
| 2026-03-18 | 16.73 |
| 2026-03-17 | 16.78 |
| 2026-03-16 | 17.00 |
| 2026-03-13 | 16.63 |
| 2026-03-12 | 16.85 |
| 2026-03-11 | 16.74 |
| 2026-03-10 | 17.70 |
| 2026-03-09 | 17.66 |
| 2026-03-06 | 17.71 |
| 2026-03-05 | 17.47 |
| 2026-03-04 | 17.76 |
| 2026-03-03 | 17.60 |
| 2026-03-02 | 17.81 |
| 2026-02-27 | 17.18 |
| 2026-02-26 | 16.85 |
| 2026-02-25 | 16.78 |
| 2026-02-24 | 17.29 |
| 2026-02-23 | 17.29 |
| 2026-02-20 | 16.56 |
| 2026-02-19 | 16.94 |
| 2026-02-18 | 16.69 |
| 2026-02-17 | 16.44 |
| 2026-02-13 | 15.92 |
| 2026-02-12 | 16.05 |
| 2026-02-11 | 18.60 |
| 2026-02-10 | 18.83 |
| 2026-02-09 | 18.65 |
| 2026-02-06 | 18.66 |
| 2026-02-05 | 18.26 |
| 2026-02-04 | 18.45 |
| 2026-02-03 | 18.87 |
| 2026-02-02 | 18.78 |
| 2026-01-30 | 18.99 |
| 2026-01-29 | 18.81 |
| 2026-01-28 | 18.68 |
| 2026-01-27 | 20.05 |
| 2026-01-26 | 19.62 |
| 2026-01-23 | 19.77 |
| 2026-01-22 | 19.20 |
| 2026-01-21 | 18.20 |
| 2026-01-20 | 18.10 |
| 2026-01-16 | 17.29 |
| 2026-01-15 | 18.06 |
| 2026-01-14 | 18.25 |
| 2026-01-13 | 18.06 |
| 2026-01-12 | 17.53 |
| 2026-01-09 | 17.05 |
| 2026-01-08 | 17.53 |
| 2026-01-07 | 17.91 |
| 2026-01-06 | 17.58 |
| 2026-01-05 | 17.90 |
| 2026-01-02 | 17.91 |
| 2025-12-31 | 17.91 |
| 2025-12-30 | 17.58 |
| 2025-12-29 | 17.72 |
| 2025-12-26 | 17.55 |
| 2025-12-24 | 17.87 |
| 2025-12-23 | 17.57 |
| 2025-12-22 | 17.59 |
| 2025-12-19 | 16.80 |
| 2025-12-18 | 16.78 |
| 2025-12-17 | 17.03 |
| 2025-12-16 | 17.81 |
| 2025-12-15 | 17.91 |
| 2025-12-12 | 18.51 |
| 2025-12-11 | 17.65 |
| 2025-12-10 | 16.90 |
| 2025-12-09 | 16.51 |
| 2025-12-08 | 17.39 |
| 2025-12-05 | 17.25 |
| 2025-12-04 | 17.52 |
| 2025-12-03 | 16.84 |
| 2025-12-02 | 16.98 |
| 2025-12-01 | 17.71 |
| 2025-11-28 | 17.83 |
| 2025-11-26 | 17.64 |
| 2025-11-25 | 17.35 |
| 2025-11-24 | 17.55 |
| 2025-11-21 | 17.68 |
| 2025-11-20 | 17.60 |
| 2025-11-19 | 17.82 |
| 2025-11-18 | 18.23 |
| 2025-11-17 | 18.19 |
| 2025-11-14 | 17.17 |
| 2025-11-13 | 17.34 |
| 2025-11-12 | 23.58 |
| 2025-11-11 | 23.81 |
| 2025-11-10 | 23.20 |
| 2025-11-07 | 23.41 |
| 2025-11-06 | 23.59 |
| 2025-11-05 | 23.41 |
| 2025-11-04 | 24.65 |
| 2025-11-03 | 23.79 |
| 2025-10-31 | 23.86 |
| 2025-10-30 | 24.11 |
| 2025-10-29 | 24.35 |
| 2025-10-28 | 24.37 |
| 2025-10-27 | 24.06 |
| 2025-10-24 | 23.91 |
| 2025-10-23 | 23.79 |
| 2025-10-22 | 23.99 |
| 2025-10-21 | 23.74 |
| 2025-10-20 | 24.29 |
| 2025-10-17 | 24.92 |
| 2025-10-16 | 24.51 |
| 2025-10-15 | 24.52 |
| 2025-10-14 | 24.70 |
| 2025-10-13 | 24.67 |
| 2025-10-10 | 24.80 |
| 2025-10-09 | 25.42 |
| 2025-10-08 | 24.87 |
| 2025-10-07 | 24.84 |
| 2025-10-06 | 24.96 |
| 2025-10-03 | 24.15 |
| 2025-10-02 | 23.79 |
| 2025-10-01 | 24.16 |
| 2025-09-30 | 23.53 |
| 2025-09-29 | 22.68 |
| 2025-09-26 | 22.73 |
| 2025-09-25 | 22.46 |
| 2025-09-24 | 22.88 |
| 2025-09-23 | 22.96 |
Showing the most recent 260 of 2,939 data points. The chart above shows the full history.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.